IGFBP2 and Ewing sarcoma: It has been shown that IGFBP-2 is able to exert intrinsic effects on a Ewing sarcoma, and on a breast cancer, cell line by binding to cell surfaces through its RGD recognition sequence (Schutt et al, 2004).